Recombinant Mycobacterium avium UPF0233 membrane protein MAV_0015 (UniProt ID: A0Q8S8) is a full-length membrane protein encoded by the crgA gene in Mycobacterium avium. It belongs to the UPF0233 family of uncharacterized proteins and is also referred to as Cell division protein CrgA . The protein spans 93 amino acids (aa 1–93) and is expressed with an N-terminal His tag for purification and detection .
The protein is primarily produced in E. coli using recombinant expression systems. Key production parameters include:
| Parameter | Details |
|---|---|
| Expression Host | E. coli |
| Tag | N-terminal His tag |
| Protein Length | Full-length (1–93 aa) |
| Purity | >90% (SDS-PAGE) |
| Storage Buffer | Tris/PBS-based buffer with 6% trehalose (pH 8.0) |
| Reconstitution | Lyophilized powder dissolved in deionized water (0.1–1.0 mg/mL) |
| Recommended Additives | 5–50% glycerol for long-term storage at -20°C/-80°C |
MAV_0015 is utilized in vaccine research due to its potential as an immunogenic target. Recombinant proteins like MAV_0015 enable the study of immune responses to M. avium antigens, particularly in the context of Mycobacterium avium complex (MAC) infections .
MAV_0015 serves as a substrate in ELISA kits for detecting M. avium infections. These kits leverage the protein’s immunogenicity to identify serological responses in clinical or environmental samples .
Functional Characterization: The UPF0233 family remains poorly annotated, and MAV_0015’s role in M. avium pathogenicity or survival is not well-defined.
Host-Pathogen Interactions: No studies directly link MAV_0015 to virulence mechanisms, such as nutrient acquisition or immune evasion.
Cross-Species Relevance: Comparative studies with other M. avium subspecies (e.g., M. avium subsp. hominissuis) could clarify its evolutionary significance .
Involved in cell division.
KEGG: mav:MAV_0015
MAV_0015 is a UPF0233 membrane protein from Mycobacterium avium, also known as Cell division protein CrgA. It is encoded by the crgA gene located at positions 14814-15095 on the negative strand of the Mycobacterium avium 104 complete genome. The gene is 282 base pairs long and encodes a protein of 94 amino acids. MAV_0015 belongs to Orthogroup Number 11 and has orthologous genes in several other mycobacterial species .
The full amino acid sequence of MAV_0015 protein (residues 1-93) is:
MPKSKVRKKNDFTVSAVSRTPVKVKVGPSSVWFVALFIGLMLIGLVWLMVFQLAAVGSQAPTALNWMAQLGPWNYAIAFAFMITGLLLTMRWH
MAV_0015 is classified as a membrane protein, suggesting it contains hydrophobic regions that anchor it within the cell membrane. Analysis of its amino acid sequence reveals hydrophobic stretches consistent with transmembrane domains. As a UPF0233 family protein, it shares conserved structural features with other members of this family, though the specific three-dimensional structure of MAV_0015 has not been fully characterized in the provided literature .
Mycobacterium avium complex (MAC) infections are increasingly common worldwide and can be difficult to treat, often requiring a year or more of antibiotic therapy. While the specific role of MAV_0015 in pathogenesis is not directly addressed in the search results, as a cell division protein, it likely plays a role in bacterial replication and survival. Understanding proteins involved in essential cellular processes like cell division could potentially reveal new therapeutic targets for treating MAC infections, which have a mortality rate of approximately 25% within 5 years .
MAV_0015 has several orthologs in other mycobacterial species, including Rv0011c in Mycobacterium tuberculosis, MAP0013c in Mycobacterium avium subsp. paratuberculosis, and ML0013 in Mycobacterium leprae. Comparative functional analysis of these orthologs can provide insights into conserved biological roles across pathogenic mycobacteria. Research methodologies should include:
Sequence alignment of all orthologs to identify conserved domains
Structural prediction using homology modeling
Gene knockout studies in multiple species to compare phenotypic effects
Complementation experiments to test functional conservation
Protein-protein interaction studies to map conserved interactomes
To elucidate the membrane topology of MAV_0015, researchers should consider a multi-method approach:
Computational prediction: Use algorithms like TMHMM, Phobius, or TOPCONS to predict transmembrane regions
Cysteine scanning mutagenesis: Introduce cysteine residues at various positions and determine their accessibility to membrane-impermeable reagents
Protein fusion techniques: Create fusions with reporter proteins (e.g., GFP, PhoA) at different positions to determine cytoplasmic versus periplasmic localization
Protease protection assays: Determine which regions are protected from proteolytic digestion by the membrane
Cryo-electron microscopy: For high-resolution structural analysis in native-like membrane environments
Researchers studying MAV_0015 function may encounter contradictory experimental results due to:
Expression system variations: Different expression systems (native versus recombinant) may yield proteins with different functional properties
Tag interference: The N-terminal His tag used in recombinant expression may affect protein folding or function
Membrane environment differences: The lipid composition of expression host membranes differs from native Mycobacterium avium membranes
Strain-specific effects: Different M. avium strains may exhibit variations in MAV_0015 function
To address these contradictions, implement:
Multiple complementary approaches for functional analysis
Both in vitro and in vivo assays
Controls using untagged protein where possible
Based on available literature, the following protocol is recommended for recombinant expression and purification of MAV_0015:
Expression system: E. coli with an N-terminal His tag fusion
Expression construct: Full-length MAV_0015 (amino acids 1-93) in a suitable expression vector
Induction conditions: Optimize IPTG concentration and temperature (typically 0.5-1 mM IPTG at 18-25°C)
Lysis: Gentle membrane disruption to preserve protein structure
Purification: Immobilized metal affinity chromatography (IMAC) using the N-terminal His tag
Storage: As lyophilized powder or in Tris/PBS-based buffer with 6% trehalose, pH 8.0
Reconstitution: In deionized sterile water to a concentration of 0.1-1.0 mg/mL with 5-50% glycerol for long-term storage at -20°C/-80°C
To study MAV_0015 in its native membrane environment:
Membrane vesicle isolation: Generate giant plasma membrane vesicles (GPMVs) from cells expressing tagged MAV_0015
Vesicle orientation: Ensure outside-out orientation of membrane proteins through selective enrichment using affinity-based methods
Vesicle sonication: Convert GPMVs to small unilamellar vesicles (SUVs) for biophysical studies
Affinity enrichment: Use tag-specific nanobodies to isolate vesicles containing MAV_0015
Verification: Confirm protein presence and orientation using SDS-PAGE and Western blotting
Functional assays: Perform assays directly on the membrane vesicles to maintain native lipid environment
Table 1: Comparison of Methods for Studying Membrane Proteins
| Method | Advantages | Limitations | Suitability for MAV_0015 |
|---|---|---|---|
| Detergent solubilization | High yield, purity | May disrupt native structure | Moderate |
| Nanodiscs | Native-like lipid bilayer | Complex preparation | High |
| Membrane vesicles | Native lipid environment | Lower yield | Very high |
| Liposome reconstitution | Controlled lipid composition | Potential refolding issues | High |
| Cryo-EM | High-resolution structure | Requires stable protein | To be determined |
To establish structure-function relationships for MAV_0015, employ the following analytical techniques:
Circular dichroism (CD) spectroscopy: Determine secondary structure content and stability
NMR spectroscopy: Analyze protein dynamics and ligand interactions
Site-directed mutagenesis: Identify critical residues for function
Cross-linking studies: Map protein-protein interaction interfaces
Molecular dynamics simulations: Model protein behavior in membrane environments
Functional assays: Measure cell division effects in complementation studies
Immunoprecipitation: Identify interaction partners in vivo
For each technique, compare wild-type MAV_0015 with mutant variants targeting conserved residues to establish structure-function correlations
A comprehensive evolutionary analysis of MAV_0015 should include:
Multiple sequence alignment: Align MAV_0015 with orthologs from related species
Phylogenetic tree construction: Use maximum likelihood or Bayesian methods
Selection pressure analysis: Calculate dN/dS ratios to identify conserved functional regions
Consensus sequence determination: Identify invariant residues across mycobacterial species
Domain architecture analysis: Map conserved functional domains
Table 2: Key Orthologs of MAV_0015 (CrgA) Across Mycobacterial Species
| Species | Gene ID | Protein Length | Sequence Identity | Functional Status |
|---|---|---|---|---|
| M. avium 104 | MAV_0015 | 94 aa | 100% | Cell division protein |
| M. tuberculosis | Rv0011c | 93 aa | ~85% | Cell division protein |
| M. leprae | ML0013 | 93 aa | ~82% | Putative function |
| M. smegmatis | MSMEG_0026 | 93 aa | ~78% | Putative function |
| M. marinum | - | 94 aa | ~80% | Putative function |
When analyzing functional data from MAV_0015 genetic manipulation studies:
For growth rate comparisons:
Use repeated measures ANOVA with post-hoc tests
Apply Bonferroni correction for multiple comparisons
Consider mixed effects models for studies with random factors
For cell morphology assessments:
Employ non-parametric tests (Mann-Whitney U) for non-normally distributed data
Use chi-square tests for categorical morphological classifications
Consider machine learning approaches for automated morphological analysis
For gene expression studies:
Apply ANOVA or t-tests with appropriate multiple testing corrections
Use fold-change cutoffs in combination with statistical significance
Perform clustered analysis to identify co-regulated genes
Data visualization recommendations:
MAV_0015 research has significant implications for understanding and treating MAC infections:
Infection mechanisms: As a cell division protein, MAV_0015 may be critical for bacterial replication during infection
Therapeutic targeting: Essential bacterial proteins like MAV_0015 represent potential drug targets
Diagnostic applications: MAV_0015-specific antibodies could be developed for diagnostic purposes
Virulence connections: Understanding the relationship between cell division and virulence factors
Drug resistance mechanisms: Potential connections between cell division proteins and antibiotic resistance
MAC infections are increasingly prevalent worldwide and often difficult to treat, requiring extended antibiotic regimens. They are particularly problematic in patients with underlying lung conditions or compromised immunity, with mortality rates of approximately 25% within 5 years. Research on essential proteins like MAV_0015 could lead to new therapeutic approaches for these challenging infections .
Priority research directions for MAV_0015 should include:
High-resolution structural studies: Determine the three-dimensional structure using cryo-EM or X-ray crystallography
In vivo functional studies: Create conditional knockdowns to study essentiality in various growth conditions
Protein-protein interaction network: Identify the complete interactome of MAV_0015
Post-translational modifications: Characterize any modifications that regulate activity
Drug discovery: Screen for small molecules that bind to and inhibit MAV_0015 function
Structure-based mutagenesis: Create point mutations in key residues to map functional domains
Comparative genomics: Study natural variations in clinical isolates and their functional consequences
Systems biology approaches: Integrate transcriptomic and proteomic data to place MAV_0015 in broader cellular networks
When working with recombinant MAV_0015, researchers may encounter several challenges:
Low expression yields:
Optimize codon usage for the expression host
Test multiple expression strains (BL21, C41/C43, Rosetta)
Reduce expression temperature (18°C overnight)
Try autoinduction media instead of IPTG induction
Protein aggregation:
Include detergents (DDM, LDAO) during lysis
Test fusion partners (MBP, SUMO) to enhance solubility
Use specialized E. coli strains designed for membrane proteins
Apply on-column refolding protocols during purification
Proteolytic degradation:
Include protease inhibitor cocktails in all buffers
Reduce purification time by optimizing protocols
Perform purification at 4°C
Consider adding stabilizing agents (glycerol, trehalose)
Reconstitution issues:
To validate the proper folding and functionality of purified MAV_0015:
Biophysical characterization:
Circular dichroism (CD) spectroscopy to assess secondary structure
Thermal shift assays to determine protein stability
Size exclusion chromatography to verify monodispersity
Dynamic light scattering to check for aggregation
Functional verification:
Binding assays with known interaction partners
Complementation studies in knockout strains
Activity assays relevant to cell division function
Structural integrity:
Limited proteolysis to verify compact folding
Native PAGE to assess oligomeric state
Intrinsic fluorescence to monitor tertiary structure
Quality control metrics:
A comprehensive research program on MAV_0015 should:
Integrate multiple approaches: Combine structural, functional, and genetic methods
Address clinical relevance: Connect fundamental research to MAC infection outcomes
Employ comparative biology: Leverage knowledge from better-studied mycobacterial orthologs
Develop specialized tools: Create antibodies, reporter strains, and expression systems
Form collaborative networks: Engage experts in membrane protein biology, mycobacteriology, and structural biology
Establish standardized protocols: Develop reproducible methods for expression and functional characterization
Consider translational aspects: Identify paths to therapeutic or diagnostic applications